catheter ablation
catheter ablation is a medical device with 116 clinical trials. Currently 21 active trials ongoing. Historical success rate of 75.0%.
Success Metrics
Based on 39 completed trials
Phase Distribution
Phase Distribution
1
Early Stage
1
Mid Stage
26
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
68.4%
39 of 57 finished
31.6%
18 ended early
21
trials recruiting
116
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Durability of Pulmonary Vein Isolation With Farapulse System Using Minimal Fluoroscopy
SAfety and eFfectiveness of cathetER Ablation for Atrial Fibrillation With Intracranial Hemorrhage (SAFER-AF)
Ablation With Transcatheter Edge-to-edge Repair for Atrial Functional Mitral Regurgitation and Atrial Fibrillation
ULTRA-HFIB-Redo: Ultrasound-based Renal Sympathetic Denervation vs Control in Redo Ablation Patients
Venous Ethanol for Ventricular Tachycardia
Clinical Trials (116)
Durability of Pulmonary Vein Isolation With Farapulse System Using Minimal Fluoroscopy
SAfety and eFfectiveness of cathetER Ablation for Atrial Fibrillation With Intracranial Hemorrhage (SAFER-AF)
Ablation With Transcatheter Edge-to-edge Repair for Atrial Functional Mitral Regurgitation and Atrial Fibrillation
ULTRA-HFIB-Redo: Ultrasound-based Renal Sympathetic Denervation vs Control in Redo Ablation Patients
Venous Ethanol for Ventricular Tachycardia
Real-world Experience of Catheter Ablation for the Treatment of Arrhythmias
A Multicenter Feasibility Study With the VERAFEYE Imaging and Guidance System as Anatomical Navigation System
Wellbeing and Survival Improvement With Event Reduction by Ablation for Atrial Fibrillation in the Very Elderly
Catheter Ablation for Functional Mitral Regurgitation in Persistent Atrial Fibrillation: Development and Validation of a Predictive Model-A Multicenter Prospective Cohort Study
Prophylactic Pulmonary Vein Isolation During Atrial Flutter Ablation
Characterization of Arrhythmia Substrate to Ablate Persistent Atrial Fibrillation
CASTLE-HFpEF (Catheter Ablation for Atrial Fibrillation Patients With Heart Failure With Mildly Reduced and Preserved Ejection Fraction)
Discontinuation of Anticoagulations After Successful Catheter Ablation of Atrial Fibrillation
Correlation of the Arrhythmia Mechanism and Substrate to Ablate Persistent Atrial Fibrillation Study
Anti-arrhythmic Therapy vs Catheter Ablation as First Line Treatment for AICD Shock Prevention
Cryoballoon/Radiofrequency/Pulsed Field Ablation of Atrial Fibrillation Versus Medical Treatment for Heart
Circulating BDNF in Patients With Atrial Fibrillation Undergoing Catheter Ablation or Exercise Training
Ablation of Consecutive Atrial Tachycardia
Impact of Catheter Ablation on ABC Risk Scores
Catheter Ablation Versus Anti-arrhythmic Drugs for Premature Ventricular Complexes
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 116